Patents by Inventor Lieming XU

Lieming XU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9161959
    Abstract: Use of a vegetable drug composition in the manufacturing of a pharmaceutical preparation for the treatment of portal hypertension caused by hepatocirrhosis, said preparation comprises 25-38% of extract of radix Salviae Miltiorrhizae, 20-25% of extract of herb Gynostemmae Pentaphylli, 1-6% of alcoholic extract of fructus Schisandrae Chinensis, 19-26% of extract of Cordyceps, 6-8% of extract of pollen Pini, 6-10% of extract of semen Persicae. Said preparation can improve hepatic cell degeneration, necrosis, intraheptic hemorrhage, fiber proliferation, and reduce pressure of portal vein in mammal. A preparation method of said preparation is disclosed.
    Type: Grant
    Filed: April 28, 2008
    Date of Patent: October 20, 2015
    Assignee: SHANGHAI SUNDISE CHINESE MEDICINE TECHNOLOGY DEVELOPMENT CO., LTD
    Inventors: Lieming Xu, Cheng Liu, Ping Liu
  • Publication number: 20100119541
    Abstract: Use of a vegetable drug composition in the manufacturing of a pharmaceutical preparation for the treatment of portal hypertension caused by hepatocirrhosis, said preparation comprises 25-38% of extract of radix Salviae Miltiorrhizae, 20-25% of extract of herb Gynostemmae Pentaphylli, 1-6% of alcoholic extract of fructus Schisandrae Chinensis, 19-26% of extract of Cordyceps, 6-8% of extract of pollen Pini, 6-10% of extract of semen Persicae. Said preparation can improve hepatic cell degeneration, necrosis, intraheptic hemorrhage, fibre proliferation, and reduce pressure of portal vein in mammal. A preparation method of said preparation is disclosed.
    Type: Application
    Filed: April 28, 2008
    Publication date: May 13, 2010
    Inventors: Lieming Xu, Cheng Liu
  • Publication number: 20100069325
    Abstract: A pharmaceutical composition for treatment of chronic liver diseases, the composition including at least cordyceps sinensis polysaccharide, amygdaloside, and gypenoside. The pharmaceutical composition slows down liver fibrosis, stops the development thereof, or reverses the same. A method of using the pharmaceutical composition for treatment of chronic liver diseases.
    Type: Application
    Filed: September 14, 2009
    Publication date: March 18, 2010
    Inventors: Yiyang HU, Ping LIU, Xuemei LI, Qin FENG, Jinghua PENG, Lieming XU, Chenghai LIU